STEMCELL Technologies Introduces AggreWell™400 For Standardized Embryonic Stem Cell And Induced Pluripotent Stem Cell Research

Main Category: Stem Cell Research
Article Date: 21 Aug 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC).

"The AggreWell™400 plate standardizes a critical step in the development of embryonic and induced pluripotent stem cells into clinically-relevant mature cells," says Clive Glover, Ph.D., STEMCELL Technologies' Product Manager for Pluripotent Stem Cell Biology. "These cells have been difficult to work with because of the lack of standardized methods to culture and differentiate them. The AggreWell™400 plate is the latest product in STEMCELL Technologies' portfolio that addresses the need for standardized methods and tools for stem cell research."

Many protocols for inducing the development ESC and iPSC into clinically relevant cell types rely on the formation of embryoid bodies (EBs), which are 3-dimensional aggregates of cells. In addition to being labor-intensive, current methods for making EBs results in aggregates that are inconsistent in size and shape, leading to inefficient differentiation.

In contrast, researchers using the AggreWell™400 plates are able to control the size of EBs, enabling them to optimize their differentiation protocols. Additionally the AggreWell™400 plates allow stem cell scientists to easily create large quantities of uniformly-sized EBs

For more information about the AggreWell™400 plates, visit here.

About STEMCELL Technologies

STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, is a privately-owned biotechnology company based in Vancouver, Canada. Driven by science, STEMCELL Technologies delivers over 800 products to more than 70 countries worldwide including mTeSR™1, a defined, feeder-independent medium for hESC and hiPSC.

STEMCELL Technologies

Article adapted by Medical News Today from original press release.
Visit our stem cell research section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
STEMCELL Technologies. "STEMCELL Technologies Introduces AggreWell™400 For Standardized Embryonic Stem Cell And Induced Pluripotent Stem Cell Research." Medical News Today. MediLexicon, Intl., 21 Aug. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/118856.php>

APA
STEMCELL Technologies. (2008, August 21). "STEMCELL Technologies Introduces AggreWell™400 For Standardized Embryonic Stem Cell And Induced Pluripotent Stem Cell Research." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/118856.php.

Please note: If no author information is provided, the source is cited instead.


Stem Cell Research

What are Stem Cells?

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: embryonic stem cells and adult stem cells Read more...

Most Popular Articles



Follow Our Stem Cell Research News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Stem Cell Research Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »